
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.24 | 2.15 | 0.91 |
Shares | 98.75 | 98.78 | 0.03 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.65 | 20.43 |
Price to Book | 4.08 | 4.06 |
Price to Sales | 2.23 | 2.45 |
Price to Cash Flow | 15.33 | 16.38 |
Dividend Yield | 1.94 | 1.37 |
5 Years Earnings Growth | 9.40 | 12.09 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.59 | 94.85 |
Basic Materials | 0.33 | 1.30 |
Consumer Defensive | 0.05 | 3.35 |
Financial Services | 0.02 | 8.91 |
Number of long holdings: 185
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.51 | 739.40 | -6.30% | |
UnitedHealth | US91324P1021 | 6.47 | 530.91 | -1.76% | |
J&J | US4781601046 | 4.80 | 155.00 | -3.02% | |
AbbVie | US00287Y1091 | 4.32 | 190.95 | -5.30% | |
Novo Nordisk B | DK0062498333 | 3.68 | 432.0 | -5.45% | |
Merck&Co | US58933Y1055 | 3.47 | 81.73 | -5.39% | |
Roche Holding Participation | CH0012032048 | 2.79 | 261.80 | -6.00% | |
Thermo Fisher Scientific | US8835561023 | 2.75 | 443.96 | -5.55% | |
Novartis | CH0012005267 | 2.71 | 92.03 | -5.42% | |
Abbott Labs | US0028241000 | 2.70 | 125.16 | -4.92% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 3.2B | 4.50 | 15.58 | 15.55 | ||
Legal General US Index Trust C Dist | 744.52M | 4.51 | 15.59 | 15.55 | ||
Legal General US Index Trust I Acc | 1.48B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust I Dist | 1.53B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust F Acc | 495.04K | 4.46 | 15.26 | 15.22 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review